Adage Capital Partners’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-425,000
| Closed | -$5.81M | – | 1017 |
|
|
2022
Q3 | $5.81M | Sell |
425,000
-25,000
| -6% | -$342K | 0.01% | 759 |
|
|
2022
Q2 | $8.25M | Buy |
450,000
+200,000
| +80% | +$3.67M | 0.02% | 716 |
|
|
2022
Q1 | $4.02M | Buy |
+250,000
| New | +$4.02M | 0.01% | 853 |
|
|
2020
Q4 | – | Sell |
-1,500,450
| Closed | -$46M | – | 857 |
|
|
2020
Q3 | $46M | Sell |
1,500,450
-309,000
| -17% | -$9.47M | 0.12% | 190 |
|
|
2020
Q2 | $29.5M | Buy |
1,809,450
+1,259,450
| +229% | +$20.5M | 0.08% | 292 |
|
|
2020
Q1 | $5.47M | Buy |
550,000
+500,000
| +1,000% | +$4.98M | 0.02% | 564 |
|
|
2019
Q4 | $688K | Hold |
50,000
| – | – | ﹤0.01% | 686 |
|
|
2019
Q3 | $759K | Hold |
50,000
| – | – | ﹤0.01% | 692 |
|
|
2019
Q2 | $985K | Hold |
50,000
| – | – | ﹤0.01% | 680 |
|
|
2019
Q1 | $830K | Buy |
+50,000
| New | +$830K | ﹤0.01% | 663 |
|